Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis- An Investigator-initiated, Phase IV, Randomised Double-blind Multi-centre Trial of the Benefits and Harms of Aripiprazole Versus Quetiapine in Children and Adolescents With Psychosis

NCT01119014 is registered in ClinicalTrials.gov with Anne Katrine Pagsberg as lead sponsor.

NCT NCT01119014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01119014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis- An Investigator-initiated, Phase IV, Randomised Double-blind Multi-centre Trial of the Benefits and Harms of Aripiprazole Versus Quetiapine in Children and Adolescents With Psychosis
Lead sponsor
Anne Katrine Pagsberg
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2010
Completion date
July 31, 2015
Enrollment
300 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis